马清霞

马清霞

      2022年博士毕业于青岛大学。 研究方向为抗肿瘤药理研究、肿瘤分子生物学研究。目前已发表SCI （含二作）四篇，中文核心一篇。

Personal Information

Name: Qingxia Ma

Date of Birth: Oct 14, 1992

Place of Birth: Shandong

Marriage Statue: Single

Passport Number: E86242992

Telephone: 86-18724702306

E-mail: 2513896687@qq.com

Address:

Qingdao University,

38 Dengzhou Road,

Qingdao,

China 260021

Education

2011-2015: Bachelor in Pharmaceutical Engineering, Shandong University of Traditional Chinese Medicine

2015-2018: Ph.D. student in Pharmacology, School of Pharmacy, Qingdao University

2021-now: post-doctoral at Qingdao University

Research Experiences

Study on the tumor metabolic。

Representative papaer

1. Ma Q , Song J , Wang S , et al. MUC1 regulates AKT signaling pathway by upregulating EGFR expression in ovarian cancer cells - ScienceDirect[J]. Pathology - Research and Practice, 2021.

2. Ma Q ,  Xu Q ,  Zhao J , et al. Coupling HDAC4 with transcriptional factor MEF2D abrogates SPRY4-mediated suppression of ERK activation and elicits hepatocellular carcinoma drug resistance[J]. Cancer Letters, 2021(Suppl).

3. Ma Q ,  Meng Z ,  Meng Y , et al. A moonlighting function of choline kinase alpha 2 in the initiation of lipid droplet lipolysis in cancer cells[J]. 2021, 41(10):4.

4. Ma Q ,  Jiang H ,  Ma L , et al. Governing glutaminolysis by regulation of glutaminase succinylation[J]. 2022, 13(3):4.